Bill Poulos

384 POSTS 1 COMMENTS
Bill Poulos has been analyzing the markets and investing since the early 70s. Investing used to be only a much loved hobby of his but in 2001, after retiring from his day job as an automotive executive at GM, he cofounded Profits Run, Inc. He and his son (Greg) now help individuals become smarter investors while properly managing risk.

Shocking “Bull Ratio” Reveals Market Imbalances

Sorry, bulls: “No deal.” That’s what Senate Majority Leader Mitch McConnell told bipartisan policymakers after they presented him with a $908 billion proposal. House Majority Leader...

Will Congress “Kill” the Bull Market?

After opening higher this morning, stocks quickly retreated. The rally seems to finally be losing steam as bulls slow down. All three major indexes are...

Why Bulls Need a Vaccine Deployment ASAP

After last week’s strong stretch of trading sessions, stocks are getting off to a much weaker start this morning. Investors continue to watch Covid-19...

Bulls Love the “Bad” November Jobs Report

A worse than expected jobs report and surging Covid-19 cases. It’s the kind of the stuff that would’ve sent stocks spiraling in the past. But...

Is the Stock Market Going Up in December?

Stocks jumped higher this morning in a bullish breakout that sent two of the major indexes to new all-time highs. The S&P 500, in...

Will Stocks Ever Go Down? Not With the Fed Helping Out

The Dow (+0.05%) and S&P (+0.20%) are trading relatively flat again this morning while the Nasdaq Composite enjoys a modest gain (+1.00%). It’s a...

“Amazon Dip” Presents Major Buying Opportunity

It’s almost Thanksgiving and Covid-19 infections continue to rise alongside stocks. And while that seems like a trend that can’t continue, in reality, investors...

How Hedge Fund Bulls Could “Kill” the Stock Market’s Rally

Covid-19 infections are surging across the U.S., Trump’s legal team says they have enough evidence to overturn the election results, and Treasury Secretary Steven...

BofA Report Suggests Wall Street Is “Too Bullish”

The bulls made a slight comeback this morning. But have they already gone too far? The Dow and S&P rose through the trading session’s...

Moderna’s Vaccine Is Likely Better Than Pfizer’s

Look out Pfizer (NYSE: PFE), here comes Moderna (NASDAQ: MRNA). That’s right, just a week after BioNTech (NASDAQ: BNTX) and Pfizer announced their more than...